Detalhe da pesquisa
1.
Risk of hyperkalaemia in patients with type 2 diabetes mellitus prescribed with SGLT2 versus DPP-4 inhibitors.
Eur Heart J Cardiovasc Pharmacother
; 10(1): 45-52, 2024 Jan 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37942588
2.
Glycated Hemoglobin Variability Is Associated With Adverse Outcomes in Patients With Heart Failure Irrespective of Diabetic Status.
J Am Heart Assoc
; 13(9): e034109, 2024 May 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-38686852
3.
Major adverse cardiovascular events of enzalutamide versus abiraterone in prostate cancer: a retrospective cohort study.
Prostate Cancer Prostatic Dis
; 2023 Dec 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-38049634